These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1709144)

  • 1. Two amino acid substitutions at residues 63 and 67 between HLA-B51 and HLA-Bw52 form multiple epitopes recognized by allogeneic T cells.
    Yamamoto J; Hiraiwa M; Hayashi H; Tanabe M; Kano K; Takiguchi M
    Immunogenetics; 1991; 33(4):286-9. PubMed ID: 1709144
    [No Abstract]   [Full Text] [Related]  

  • 2. Discrimination of HLA-B5 crossreactive group antigens by human allospecific CTL clones.
    Matsumoto K; Yamamoto J; Hiraiwa M; Kano K; Takiguchi M
    Transplantation; 1990 Jun; 49(6):1164-7. PubMed ID: 2360256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the substitutions in the alpha helix and the beta sheet of HLA class I molecule on allorecognition of T cells specific for HLA-B51 and HLA-Bw53.
    Hiraiwa M; Nishimura I; Kato N; Nagao T; Kano K; Takiguchi M
    Hum Immunol; 1992 Feb; 33(2):82-8. PubMed ID: 1373416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
    Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A
    Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules.
    Tomiyama H; Sakaguchi T; Miwa K; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    Hum Immunol; 1999 Mar; 60(3):177-86. PubMed ID: 10321954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha 1 domain.
    Hayashi H; Ennis PD; Ariga H; Salter RD; Parham P; Kano K; Takiguchi M
    J Immunol; 1989 Jan; 142(1):306-11. PubMed ID: 2909619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51.
    Thimme R; Chang KM; Pemberton J; Sette A; Chisari FV
    J Virol; 2001 Apr; 75(8):3984-7. PubMed ID: 11264388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation of human minor histocompatibility antigens by HLA-B35 and HLA-B38 molecules.
    Yamamoto J; Kariyone A; Akiyama N; Kano K; Takiguchi M
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2583-7. PubMed ID: 2157206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique murine monoclonal antibody recognizing HLA-B53, B37, B51, B52, +/-B44.
    Etessami S; Tarsitani C; Lias M; Broadous M; Conger N; Randol G; Delory M; Bahrami S; Lee JH
    Hum Immunol; 2001 Jul; 62(7):732-8. PubMed ID: 11423180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
    Ueno T; Tomiyama H; Takiguchi M
    J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of a human allo-peptide presented by HLA-B51 molecules.
    Tomiyama H; Takamiya Y; Hill AB; Cerundolo V; Kelly A; Egawa K; Trowsdale J; Takiguchi M
    Int Immunol; 1995 Jun; 7(6):905-9. PubMed ID: 7577798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B SNA.
    Sekimata M; Hiraiwa M; Andrien M; Dupont E; Karaki S; Yamamoto J; Kano K; Takiguchi M
    J Immunol; 1990 Apr; 144(8):3228-33. PubMed ID: 1691230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of single amino acid substitution at residue 167 of HLA-B51 on binding of antibodies and recognition of T cells.
    Nakayama S; Kawaguchi G; Karaki S; Nagao T; Uchida H; Kashiwase K; Akaza T; Nasuno T; Takiguchi M
    Hum Immunol; 1994 Mar; 39(3):211-9. PubMed ID: 8026989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.
    Hadida F; Haas G; Zimmermann N; Hosmalin A; Spohn R; Samri A; Jung G; Debre P; Autran B
    J Immunol; 1995 Apr; 154(8):4174-86. PubMed ID: 7535824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms.
    Ooba T; Hayashi H; Karaki S; Tanabe M; Kano K; Takiguchi M
    Immunogenetics; 1989; 30(2):76-80. PubMed ID: 2788131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1.
    Schneider J; Brichard V; Boon T; Meyer zum Büschenfelde KH; Wölfel T
    Int J Cancer; 1998 Jan; 75(3):451-8. PubMed ID: 9455808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
    Terakura S; Murata M; Warren EH; Sette A; Sidney J; Naoe T; Riddell SR
    Transplantation; 2007 May; 83(9):1242-8. PubMed ID: 17496542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule.
    Hogan KT; Clayberger C; Le AX; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Dec; 141(11):4005-11. PubMed ID: 2460555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.